Mechanistic studies of deregulated ERG in prostate cancer and other cancers continue to enhance its role in cancer biology and its utility as a biomarker and therapeutic target. Here, we show that ERG, through its physical interaction with androgen receptor, induces AR aggregation and endoplasmic reticulum stress in the prostate glands of ERG transgenic mice. Histomorphological alterations and the expression of ER stress sensors Atf6, Ire1α, Perk, their downstream effectors Grp78/BiP and eIF2α in ERG transgenic mouse prostate glands indicate the presence of chronic ER stress. Transient activation of apoptotic cell death during early age correlated well with the differential regulation of ER stress sensors, in particular Perk. Epithelial cells derived from ERG transgenic mouse prostates have increased prostasphere formation with resistance to radiation induced cell death. Continued activation of cell survival factors, Atf6 and Ire1α during chronic ER stress due to presence of ERG in prostate epithelium induces survival pathways and provides a selection pressure in the continuum of ERG dependent neoplastic process. These novel insights will enhance the understanding of the mechanistic functions of ERG in prostate tumor biology and towards development of early targeted therapeutic strategies for prostate cancer.
Prostate cancer continues to be the most commonly diagnosed and a leading cause of cancer deaths in Western countries1, 2. Similar to many cancers, prostate cancer mortality has been associated with metastasis. The genetic aberrations associating with the castration-resistant prostate cancer (CRPC), the fatal stage of the disease, are numerous and hereogeneous due to the as a consequence of genomic instability, resulting into abnormal cellular functions3. Deregulated androgen receptor (AR) signaling due to either mutations or altered expression of the AR and its cofactors (activators or suppressors) have also been identified as a critical factors in prostate cancer development, progression and metastasis4. Mutations of the driver genes, in particular, oncogenes and tumor suppressor genes play a critical role in the initiation of oncogenic process in a cell and subsequently alter the global gene expression patterns5.
Oncogenic activation of ETS Related Gene (ERG) via chromosomal rearrangements has been well established in diverse human cancers such as Ewing sarcoma6, acute myeloid leukemia7, 8 and over half of all prostate cancers in Western countries9,10,11,12. ETS related gene (ERG) fusions with androgen regulated gene promoters in prostate cancer patients constitute to a higher percentage in Caucasian men and a much lower frequency in men of African and Asian race9,10,11, 13. TMPRSS2-ERG fusion brings ERG under androgen-regulated TMPRSS2 gene promoter which encodes near full length ERG protein products with deletion of 32 amino terminal aminoacids14. Since then, several studies have focused on understanding the biological functions of ERG in prostate cancer initiation and progression14,15,16,17,18. Transgenic mouse models engineered to express human ERG gene in prostate specific manner with modified rat probasin (ARR2PB) promoter showed variable phenotypes including prostate intraepithelial neoplasia (PIN)14,15,16,17,18,19. Despite the less understood mechanistic role of ERG in tumor initiation, these mice developed adenocarcinoma upon the introduction of additional genetic mutations in PI3K/AKT/PTEN axis14, 18, 19. Moreover, expression of ERG in prostate epithelium resulted in reprogramming of the AR cistrome especially in the presence of PTEN inactivation19. A recent study showed that, ERG expressing mouse prostates developed adenocarcinoma in older mice through activation of YAP1, a critical component of Hippo pathway20.
Since the role of ERG needs to be better understood in early stages of prostate tumorigenesis, we hypothesized that ERG over expression may initiate oncogenic process through activation of cell survival mechanisms, either by abrogating luminal cell differentiation or potential immortalization to provide favorable envornoment for secondary mutations. To test this hypothesis, we focused on mechanistic aspects such as morphological and molecular alterations induced by the overexpression of ERG in prostate epithelium by extensive analysis of both ERG transgenic mouse prostate glands and LNCaP cell line transduced with and inducible lentiviral ERG construct. In these model systems, one of the most prominent and novel morphological phenotype observed was endoplasmic reticulum (ER) stress. ER stress is a condition that results due to improperly folded secretory and transmembrane proteins due to environmental insults21. Further, experiments with lentiviral ERG transduced LNCaP cells showed a physical interaction between ERG and AR, aggregation of AR protein, induction of ER stress response proteins and resistance to cell death. The results presented in this study support our hypothesis and provide a mechanism for how the overexpression of ERG results in AR aggregation, ER stress, apoptosis and eventual cell survival. Importantly, we also establish that the ERG induced ER stress is necessary for developing resistance to cell death towards the initiation of tumorigenic process.
Mouse prostate glands expressing Tg-ERG display increased cell death due to apoptosis
Prostate luminal epithelial cell targeted ERG transgenic mice, Tg (Pbsn-ERG) 1Vv [Tg-ERG]17, 20 were generated by a widely used rat probasin promoter ARR2PB22. Our comprehensive evaluations of the ERG protein in Tg-ERG mouse prostate glands revealed higher expression in ventral prostate glands compared to other lobes (ventral > lateral > dorsal > anterior) (Suppl. S1). The ERG protein levels appear to be relatively higher in the distal half of the prostate compared to proximal half of the prostate glands (Suppl. S1). Consistent with earlier reports16, 17, we also noted a significant increase of PIN lesions with increasing age of the Tg-ERG mice. To address, if variable phenotype in earlier reported ERG transgenic mouse prostates was due to low ERG protein expression, we compared levels of ERG protein in adult ERG transgenic mouse17 prostate glands with human prostate cancer specimens. We did not find any significant differences in the expression levels of ERG protein by immunohistochemistry (IHC) between Tg-ERG mouse prostate glands and ERG positive human prostate tumors (Suppl. S2A,B). A novel and prominent histological phenotype observed in the Tg-ERG mouse prostates was the increased nuclear fragmentation of luminal epithelial cells (Fig. 1B) compared to their wild-type litter-mates (Fig. 1A). The nuclear fragmentation was confirmed by TUNEL staining suggesting that the luminal epithelial cell death was due to apoptosis, which was persistent until 12 months, with the highest levels around 6 months of age (Fig. 1C D; Suppl. S3A–G). It is well established that oncogenic signals induce cellular stress responses, including metabolic stress, apoptosis, DNA damage responses, and cellular senescence23, 24. Apoptotic cell death in Tg-ERG mouse prostate glands was most frequently observed in the ventral, less so in dorso-lateral, and rarely in the anterior lobes. Therefore, we focused subsequent studies on ventral prostate associated cell death and survival events. The increased incidence of apoptosis in prostate ducts of Tg-ERG mice suggested for a well-established androgen signaling mediated differentiation state of rodent prostates25. To examine if the surviving epithelial cells facing the lumen have proliferative properties, the Tg-ERG mice analyzed for BrdU incorporation in DNA (Fig. 1E,F; Suppl. S4A–G). Histological examination revealed that the luminal epithelial cells from 30 month-old prostates exhibited altered nuclear morphology and pockets of increased clusters high grade PIN lesions (Fig. 1G,H). A small but, significant number of proliferating cells were observed in the luminal compartment of 12 month-old ERG transgenic mouse prostates which further increased in 30 month-old Tg-ERG mice (Fig. 1I–L; Suppl. S5A,B ).
Luminal epithelial cells with Tg-ERG expression display abnormal ER and ER stress
Tg-ERG prostates from 3 to 12 month-old mice processed in methyl-methacrylate for plastic sections stained with toludine blue showed increased vacuolization and altered morphology (arrows Fig. 2B) compared to the wild-type controls (Fig. 2A). Subsequent ultra-structural analysis of Tg-ERG mouse prostate glands by TEM displayed significant cytoplasmic abnormalities such as ballooned vacuoles of various sizes with filamentous content (Fig. 2C,D) that were similar to the morphological features of ER stress26. The most striking morphological difference observed was abnormally swollen ER (arrow Fig. 2D). In wild-type mouse prostate glands, the cellular cytoplasm contained flattened rough endoplasmic reticulum (ER) cisternae and secretory vesicles with different electro-densities in the apical region. The presence of the abnormally swollen ER (vacuoles) were found increased significantly in 9 months-old mouse prostates (Fig. 2E). These morphological observations of balooned ER appeared to be ERG specific and were not detected in LoMYC transgenic mouse prostates (Suppl. S6). Taken together these data suggested a dysfunctional ER in the presence of ERG overexpression.
In order to gain insights into ER stress and its effect on the stress related transcription factors, initially we performed a qualitative analysis of transcription factor activation profiling plate array assay using protein extracts from Tg-ERG mice and wild-type controls. Prostates of 3.5 month-old Tg-ERG mice showed slight up regulation of Xbp1, Gadd153/Chop, Cbf/Nfy, Serbp1, Err, Atf3 (Fig. 3A) and the magnitude of the activation of these TFs was significantly higher by 10 months of age (Fig. 3B,C). In addition, other transcription factors such as Atf4, Atf6, Atf3, and Foxo1 were also found elevated in 10 month-old Tg-ERG mouse prostates (Fig. 3B). Further, the protein extracts from prostates from 3, 7 and 11 months-old Tg-ERG mice exhibited increased expression of critical ER stress sensors proteins: Atf6, Ire1α and Perk (Fig. 4A). Activated Perk mediated phosphorylation of eIF2α showed upregulation in Tg-ERG mouse prostates (Fig. 4B). As a consequence of activated ER sensors, UPR proteins such as Pdi/P4hb and Grp78, were upregulated in Tg-ERG mouse prostates (Fig. 4D,F). In order to extend the observations of ERG associated UPR induction from ERG transgenic mice to human prostate tumors with ERG activation, we assessed the correlation of ERG and PDI/P4HB expression in our Affymetrix GeneChip dataset (NCBI, GEO: GSE32448)11. Similar to the expression of P4hb/Pdi in Tg-ERG mouse prostates, a significant correlation of P4HB/PDI up-regulation was observed in ERG positive human prostate tumors (Fig. 4G). We further examined the colocalization of ERG with the ER stress sensors in the Tg-ERG mouse prostates. Immunofluorescence analysis revealed the nuclear localization of Atf6 suggesting the activation of Atf6 in the prostate epithelium in Tg-ERG mice (Fig. 5A). Increased xpression of Ire1α and Grp78 were also observed in the prostate epithelial cells of Tg-ERG mice (Fig. 5B,C).
ERG induces ER stress through AR mis-folding/aggregation
In order to further validate ERG induced ER stress, we generated and characterized a stable cell line (lentivirus transfectants of LNCaP, LNCaP-LnTE3) with doxycycline inducible ERG3 (Fig. 6A–J). LNCaP-LnTE3 cells grown in charcoal-stripped serum (CSS) with subsequent addition of synthetic androgen, R1881(1 nM) and doxycycline (1 μg/ml) induced ERG expression displayed significant increase in the number of vacuoles (Fig. 6I,J). LNCaP-LnTE3 cells grown in regular media (supplemented with 10% FBS) upon doxycline induced ERG expression also displayed stress related phenotype of vacuole formation. ER stress transcription factor activation profiling plate array assay using protein extracts from ERG induced LNCaP-LnTE3 cells showed increased activity of transcription factors: XBP1, ATF6, GADD153/CHOP, SREBP1, ERR and ATF3 (Fig. 6K). Further, increased expression of ER sensor proteins, ATF6, IRE1α and PERK were noted in response to ERG induction (Fig. 6L). Consistent with reduced levels of Ar protein detected in Tg-ERG prostates (Fig. 4A), LNCaP-LnTE3 cells displayed reduced levels of AR protein in response to ERG induction (Fig. 6M). To further evaluate AR or AR regulated gene expression in the presence of ERG, we analyzed a well characterized AR target gene, PSA in LNCaP-LnTE3 cells (Fig. 6M). This observation was consistent with the previous findings of ERG mediated attenuation of AR-regulated PSA expression in TMPRSS2-ERG positive VCaP cells27, 28. These results indicated that ERG may interfere with the functions of AR, such as maintenance of differentiation or survival of terminally differentiated luminal epithelial cells. It has been postulated that the AR inclusions or aggregation can be induced due to physiological fluctuations such as differentiation or stress disturbances by androgens resulting into activation of ER stress29. Mechanistic studies have shown a link between AR aggregation and UPR leading to the development of Kennedy disease30. Higher concentrations of androgens are also known to aggregate AR protein leading to ER stress and cell death29, 31. Since AR is a critical molecule in development of prostate glands and disease conditions, we examined the AR aggregation by filter aggregation assay32 in the presence or absence of ERG to assess if the AR mis-folding/aggregation plays role in ERG induced ER stress. Lower R1881 concentration (1.0 nM) in the presence of ERG induction resulted in AR aggregation, comparable to a higher R1881 concentration alone (10 nM), suggesting for comparable cellular stress induced by ERG or higher R1881 concentrations (Fig. 6N). ERG in the presence of 1.0 nm R1881 appears to induce AR aggregates in a synergistic manner. Further, LNCaP-LnTE3 cells transfected with pEGFP-C1-AR33 showed nuclear aggregation of AR protein upon ERG induction. (arrow Fig. 6P) compared to controls (Fig. 6O). To assess the potential of physical interaction between ERG and AR that may be critical in impairing differentiation or compromising the AR mediated functions, we utilized proximity ligation assay (PLA) in LNCaP-LnTE3 cells to see the interactions in situ. We observed a significant interaction between ERG and AR within the native chromatin context (Fig. 7B) only with the induction of ERG by doxycycline treatment. We further examined AR interaction with ERG by utilizing the construct of 3xMYC tagged AR34. HEK293 and a stable cell line of HEK293 with constitutive expression of ERG (HEK293-TE3) were transfected with 3xMyc-AR-FL construct (Fig. 7C). Both ERG and AR-FL were expressed and were detected with anti-ERG antibodies (9FY) and Myc-Tag antibodies respectively (Fig. 7D). Immunoprecipitation of ERG followed by immunoblotting of Myc-AR revealed a significant interaction with ERG (Fig. 7E). Similar results were obtained with immunoprecipitation with Myc-tag antibodies followed by immunoblotting with ERG antibodies (Fig. 7F). Since AR was shown to for homodimers, we further examined if the ERG interactions with AR are specific to either the AR-homodimer or AR-monomer by treating TMPRSS2-ERG harboring VCaP cells with AR dimerization inhibotor (resveratrol)35. Immunoflurescence assay shows the colocalized expression of ERG and AR in the nuclei of VCaP cells (Fig. 7G–J). Results from PLA show significant ERG-AR interactions in the presence of 100 mM resveratrol suggesting that ERG interacts with AR monomers upto 48 hrs (Fig. 7K–M).
Luminal epithelial cells isolated from ERG transgenic mouse prostates show altered expression of cell surface markers, sphere forming capability and differentiation
To address the question if Tg-ERG mice prostates are enriched in prostate progenitor cells, we performed immunofluorescence for cytokeratins CK5 (basal) and CK8 (luminal) markers (Fig. 8A,B). The luminal cells in the prostate glands of 12 months-old Tg-ERG mouse showed expression of both cytokeratins CK5 and CK8 (Fig. 8B) suggesting that these double positive cells were basal-intermediate cells. Increased presence of CK5/CK8-positive basal intermediate cells was also observed in prostate specific AR conditional knock-out mouse36. To assess potential effects of ERG on differentiation block in surviving luminal epithelial cells of Tg-ERG prostates, we isolated total cells from ventral prostate glands of 12 months-old Tg-ERG mice and wild-type litter mate controls and analyzed for cell lineage (Lin-) markers (CD31, Ter119, CD45) or other cell type markers (Sca1, CD49f and CD133) by flow cytometry (Fig. 8C,D). Our analysis showed that Tg-ERG mouse ventral prostates had about 4 fold increase of viable Lin- cell population (Fig. 8E). Linneg CD49f neg/l°w Sca1med population of cells exhibited overexpression of basal/mesenchymal marker, Sca1 and down regulation of CD133 (Fig. 8F). Increased presence of this cell population in Tg-ERG mouse prostates suggested their identity as intermediate cells, which were partially differentiated and shared characteristics of both basal and luminal cells. Hence, we performed an in vitro prostate sphere assay37, 38 to determine if these cells have ability to form prostate spheres/colonies. Epithelial cells from the prostate gland of 3- to 13-month-old Tg-ERG mice showed increased sphere forming capability than wild-type littermates (Fig. 8G). Spheres formed from wild-type mouse appeared more differentiated upon the addition of the androgen hormone, DHT (Fig. 8H). However, the spheres derived from ERG-transgenic mouse showed foci without development of duct like structures, a hallmark of compromised terminal differentiation (Fig. 8I).
Induced expression of ERG confers and resistance to cell death and selective cell proliferation
To examine the cells with ER stress phenotype induced by ERG have survival capability, we isolated prostate cells from ventral prostate glands, grown as prostate spheres in the presence or absence of hormone, DHT for 48 hrs and then subjected to 0, 3 and 6 Gy radiation and spheres were maintained in culture for 7 days (Fig. 8J,K). In the post-radiation short-term cultures, Tg-ERG spheres displayed enhanced cell survival in the presence of DHT compared to wild-type prostate spheres (Fig. 8K), suggesting that expression of ERG may provide survival/growth advantage to surviving luminal cells. To further confirm these findings in human prostate cancer culture system, LNCaP-LnTE3 with or without ERG induction were subjected to 0, 3 and 6Gy radiation followed by continued culture for 14 days. Consistent with sphere cultures from the Tg-ERG mice, ERG positive LNCaP-LnTE3 cells showed enhanced cell survival (Fig. 8L). Overall the observations of increased survival of sphere cultures indicate the critical role of ERG in enriching prostate luminal epithelial cells of the Tg-ERG mice with adaptive survival.
Since the cell surface marker analysis revealed the presence of unique “skewed population of luminal cells with increased sphere forming capability, we attempted to establish cell lines from Tg-ERG mouse prostates. We could atleast establish 4 independent clones that were spontaneously immortalized with very low proliferation rate. Our initial characterization of a cell line MoE1 (mouse derived epithelial cells) grown in PrEGM (Fig. 9A) supplemented with 1 nM R1881 showed the expression of ERG and Ar by immunofluorescence (Fig. 9B–E). These cells also have shown the expression of both Ar and ERG proteins by Western blot analysis (Fig. 9F). To further characterize the the population of cells that may contribute to the increased proliferation (sphere forming capacity) in the mouse prostate glands, we performed 6 color flow cytometry for Lineage markers (CD31, TER119, CD45), stem cell markes CD49f, EpCAM, Sca1, CD133 and DAPI of ERG prostate derived spheres Tg-ERG and wild-type mice. Majority of cells from Tg-ERG derived spheres were positive for stem cell markers CD49f and Sca1. However staining with EpCAM revealed about 3 fold increase in the EpCAM negative population of ERG prostate spheres (Fig. 9Gi–iv). Analysis of MoE1 cell line showed that majority of cells (97.1%) were positive for CD49f and Sca1, but negative for EpCAM (Fig. 9H).
Since, over half of the prostate cancer patients harbor TMPRSS2-ERG fusions, understanding the mechanistic role of ERG in mediating oncogenic transformation of prostate epithelium would facilitate better therapeutic strategies. Differentiated prostate epithelial cells secrete prostatic fluids, one of the components of semen through ER mediated transport mechanism. Under normal conditions, ER orchestrates the synthesis; folding and transport of at least one third of the proteins that mediate crucial signaling roles such as cell surface receptors, transporters, or polypeptide hormones. Factors such as nutrient deprivation, hypoxia, and point-mutations in secreted proteins lead to the accumulation of misfolded proteins or aggregation within the ER, namely ER stresses. Accumulation of unfolded or misfolded proteins by these factors in the ER lumen alters the ER homeostasis and activates UPR. As cancer usually arises and progresses in a stressed cellular microenvironment, transformed cells use UPR activation as a pro-survival strategy39.
Our data show that ERG induces ER stress and, as a consequence, the canonical pathways of UPR were found differentially regulated towards cell survival. Histological analysis of Tg-ERG prostate glands revealed a transient upregulation of apoptotic cell death around 6 months. However, the luminal surface of the older Tg-ERG mouse prostate glands contained sparsely organized cells with subtle abnormal morphology with PIN lesions. We observed a slight increase in the cell proliferation as evidenced by increased ki67 staining in Tg-ERG mice over 30 months of age. Of note, we observed the presence of ballooned ER in Tg-ERG mouse prostate cells from about 5 months of age, with several abnormal sub-cellular organelles suggests ER stress (Fig. 2B,D). This observation was substantiated by the expression analysis of ER stress transcription factors (Fig. 3A,B) and 3 key sensors of ER stress pathway (Fig. 4A). Since the protein overload of ER due to potentially impaired protein folding or misfolding are well established in the induction of stress, we reasoned to examine the upstream events that induce ER stress. Several studies have shown that AR protein is aggregated due to either poly glutamine expansion or increased hormone30, 31. Our novel observations have shown that in the presence of androgen, ERG induced AR aggregation. Crucial findings of this study include the identification of ERG induced AR aggregation may have attenuated AR function. Decreased levels of Ar protein in Tg-ERG mouse prostates may refelect increased aggregation and decreased monomers as seen in aggregation assay. The presence of in situ physical interaction between ERG and AR may be a critical step to drive AR protein misfolding/aggregation. Although the precise contact points on AR for ERG interaction have not been well characterized, the ETS domain of ERG was shown to interact with AR in DNA independent manner28. It is possible that the reprogramming of AR cistrome by ERG19 may reflect AR tolerance/adaptaion for ERG subsequent to initial events of ERG/AR driven cellular stress as noted in this report. Our results suggest that the terminally differentiated luminal epithelial cells with ERG expression undergo apoptosis due to ERG-induced ER stress likely resulting form AR misfolding/aggregation. However, either upon continued expression of ERG, a subpopulation of cells of the luminal surface with altered expression of cell surface markers evades cell death due to activation of cell survival pathways (Fig. 10). Overall, our findings along with recently demonstrated activation of YAP1 of Hippo pathway by ERG in the development of age-dependent adenocarcinoma20 may be one of the mechanisms and suggests for a critical role for ERG in early pro-tumorigenic events leading to progression/development of prostate cancer in humans. Taken together, new insights from this report enhance the biochemical and biological role of ERG in early stages of prostate cancer development and its utility both as biomarker and therapeutic target.
Materials and Methods
Analysis of Tg-ERG transgenic mice
ERG transgenic mice Tg(Pbsn-ERG)1Vv (referred in this manuscript as Tg-ERG) were obtained from Dr. Valera Vasioukhin, Fred Hutchinson Cancer Research Center. The mice are maintained according to Uniformed Services University of the Health Sciences- Institutional Animal Care and User Committee (USU-IACUC) approved animal study protocols for breeding (SUR-12-597 and SUR-15-597) and research (SUR-12-581 and SUR-15-581). All experimental methods performed in this manuscript were conducted in accordance with the relevant guidelines and regulations. Mice were euthanized using CO2 asphyxiation, and prostate tissues were procured for either paraffin embedding or frozen storage for histological and molecular analyses using established protocols.
Wild-type and Tg-ERG transgenic male mouse ventral prostates were collected at different time points and processed for paraffin embedding and sectioning. The sections were stained with H&E for general histology and were scanned using a Nano Zoomer Digital Pathology system, Hamamatzu Corporation, at 40x magnification and analyzed using NDP View software.
Antibodies and plasmids
ERG (9FY, Biocare Medical Inc., CA, USA); ERG (EPR 3864; Cat No. 2805-1, Epitomics, USA); AR (#sc815, Santa Cruz Biotechnology, Inc., Dallas, TX, USA); ER Protein Folding Antibody Sampler Kit (#4759), ATF6, PERK, IRE1α, GAPDH (Cell Signaling Technology, Danvers, MA, USA); Nkx3.1 was a kind gift from Dr. Bieberich, UMBC, Baltimore, MD, USA and Tmprss2 was a kind gift from Dr. Lin, UMAB, Baltimore, MD, USA. pEGFP-C1-AR was a gift from Michael Mancini (Addgene plasmid #28235).
Total protein lysates were prepared in the MPER buffer (Biorad) supplemented with protease inhibitor cocktail and phosphatase inhibitors (Thermo Scientific, Waltham, MA) and westerns were performed as per standard protocols. The antibodies used were ERG (9FY 1:500; AR (1:2000; ATF6, PERK, IRE1α, Bip/GRP78, GRP92, ERp57, alpha-tubulin (1:1,000) and GAPDH (1:5,000).
Slides were deparaffinization in xylene, sequentially rehydrated in a descending series of ethanol concentrations followed by antigen retrieval in citrate buffer (pH 6.0) for 30 minutes. Endogenous peroxidase was blocked with 3% H2O2 for 15 min at room temperature. Primary antibodies diluted in 1xPBS were incubated overnight at 4 °C [ERG mouse monoclonal antibody (9FY-CPDR, 1:100), androgen receptor C-20 (sc815, 1:2000), Nkx3.1 (1:1000), and Tmprss2 (1:1000), GRP78 (1:1000), PDI (1:1000)]. Following the addition of appropriate secondary antibodies, the immune reactivity was visualized using DAB as chromogene (Vector #SK4100) and counterstaining with hematoxylin. Slides were then dehydrated in graded alcohol washes, cleared using xylene, and mounted for microscopic analysis.
Cells were fixed with 4% PFA buffered in PBS, permeabilized with 0.1% Triton X-100 in PBS, and blocked with 1% normal horse serum (Vector Laboratories) before incubating with appropriate primary antibodies. Species-specific secondary antibodies (Alexa Fluor-594 goat anti-mouse and Alexa Fluor-488 goat anti-rabbit (Invitrogen Corp., Carlsbad, CA, USA) were subsequently applied together with DAPI. F-actin was stained with Alexa Fluor-594 phalloidin (Invitrogen Corp., Carlsbad, CA, USA).
Electron microscopy (EM)
Prostate tissues were fixed in Kornovsky buffer (#15720, Electron Microscopy Sciences, Hatfield, PA, USA) overnight at 4 °C and washed in the same buffer for 30 min followed by post-fixation for 2 h at 4 °C in 2% Osmium tetroxide in cacodylate buffer. After fixation, the material was dehydrated through a graded series of alcohols and embedded in SpurrResin (Electron Microscopy Sciences, Hatfield, PA, USA). Samples were then polymerized at 75 °C for 12 h and sections were cut on a Leica Ultracut UC6 ultramicrotome (Leica Microsystems, Buffalo Grove, IL, USA). Copper grids containing thin sections were post-stained for 20 min in 2% uranyl acetate and 5 min in Reynold’s lead citrate before observation in a JEOL JEM-101transmission electron microscope (JEOL USA, Inc., Peabody, MA, USA). Images were captured on an AMTXR50S-A digital camera. For light microscopic analysis, semi-thin sections (2 μm) were stained with Toluidine blue.
ER stress Transcription Factor Activity Profiling Assay
Analysis of 16 ER stress/UPR related TFs was performed according to the manufacturer’s instructions using the ER Stress (UPR) TF Activation Profiling Plate Array FA-1006 (Signosis). Nuclear proteins were prepared from 3.5 and 10 months-old Tg-ERG mouse prostates and their age matching littermate controls, LNCaP-LnTE3 cells without or with doxycycline induction were prepared according to the manufacturer’s recommendations using Signosis Nuclear Extraction Kit from Signosis (SK-0001).
In situ Proximity Ligation Assay
ERG and AR interactions were detected using Duolink® In Situ Red Starter Kit Mouse/Rabbit (#DUO9201, Sigma-Aldrich, St. Louis, MO, USA). Briefly, LNCaP-LnTE3 cells grown on glass cover glass with and without ERG induction by doxycycline were washed twice in PBS, fixed for 10 min in 4% (w/v) paraformaldehyde in PBS, permeabilized for 10 min with 0.3% (v/v) Triton X-100 in PBS and blocked for 1 h with Sigma PLA blocking buffer at 37 °C. The cells were incubated with the indicated antibody pairs (mouse anti-ERG [CPDR, #9FY at 1:8000 dil] and rabbit anti-AR [Origene Technologies, Inc., Rockville, MD USA]) # TA3076387, 1:2000 dil]) at 37 °C. Secondary antibodies conjugated to PLUS and MINUS probes, ligation and amplification steps were performed according to manufacturers instructions. Images were acquired by Zeiss AxioImager. M2 microscope and StereoInvestigator 9 software.
AR aggregation assay
AR aggregate filter-trap assay was performed according to Wanker et al.32 with modifications. LNCaP cells with and without ERG induction were lysed in 200 ul cold lysis buffer (50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 0.5% Nonidet P-40, 1 mM EDTA, and protease inhibitor mixture (Active Motif, Carlsbad, CA, USA) and centrifuged for 5 min at 14,000 rpm. Each pellet was resuspended in 100 ul DNase buffer and digested with 0.5 mg/ml of DNase I at 37 °C for 1 hr. The aliquots corresponding to 50–100 μg of protein were filtered through 0.2 μm Cellulose Acetate and 0.45 μm Nitrocellulose membranes. Membranes were blocked in 5% NFD and captured aggregates were detected by immunoblotting with AR antibody and visualized using the ECL Plus kit (GE Healthcare Life Sciences, Pittsburg, PA, USA).
Prostate sphere formation assay
Age matched wild-type and Tg-ERG transgenic mouse prostates were minced into small pieces in DMEM media supplemented with 10% FBS and incubated in a final concentration of 1mg/ml of type I collagenase solution (Invitrogen, USA) for 60–90 min as described previously38. Prostates Cells were then pelleted, resuspended, and incubated in 0.05% trypsin/EDTA for 5 min at room temperature and passed through 19- to 27-gauge needles. Cells were passed through a 40-ml cell strainer and centrifuged for 6 min at 1,000 rpm. Cell pellet was resuspended in 1 ml of PrEGM and about 10,000 cells were suspended in 1:1 Matrigel (BD Pharmingen, Franklin Lakes, NJ, USA)/PrEGM in a total volume of 100 μl in triplicate and plated around the rims of wells in a 12-well plate. After the Matrigel solidified, 1 ml of PrEGM was added and the plates were stored in a CO2 incubator at 37 °C. Medium was replenished every 3 days. Ten days after plating, spheres with a diameter over 40 μm were counted.
Co-immuno-precipitations of ERG and AR
HEK-293 and HEK 293-LTE3 (HEK 293 with ERG) cells grown in serum starvation conditions (in 10% charcoal stripped serum) were transfected with 12 µg of pCMV-3MYC-AR (full length androgen receptor), pCMV-3MYC-AR:1-565, pCMV-3MYC-AR:566-919, pCMV-3MYC-AR:1-670, and pCMV-3MYC-AR:1-608 plasmids (Hoang, 2014, Mol Cell Ther). Cells were then treated with 1 nM of R1881 24 h after transfection incubated for another 24 h. Cell were lysed in Lysis buffer (50 mM Tris pH 7.9, 5 mM EDTA, 150 mM NaCl, 1% NP-40, and 1 mM Sodium orthovanadate) containing Halt protease and phosphatase inhibitors (Thermo). ERG and myc-tagged AR proteins in the cell lysates were immunoprecipitated with 4 µg anti-ERG rabbit monoclonal (Abcam EPR3864) pre-bound to Protein A/G Plus Ultralink agarose beads (Thermo Scientific) and with 30 µl of Anti-c MYC Agarose (Thermo Scientific), respectively by incubation for 4 hrs. The beads were washed three times for 15 min each in Wash buffer (10 mM Tris pH 7.9, EDTA 0.5 mM, 150 mM NaCl, 0.1% NP-40 with 1x Halt protease and phosphatase inhibitors). The cell lysates were separated on 4% to 12% Bis-Tris gels (Thermo Scientific) and transferred electrophoretically to polyvinylidene fluoride membrane (Thermo Scientific). The membranes were blocked by using ReliaBLOT® Block reagent (Bethyl Laboratories) in Tris-buffered saline and Tween 20 (TBST, 150 mM NaCl, 0.1% Tween 20, 50 mM Tris pH 8.0). Primary antibodies used for immunoblotting were anti-ERG rabbit MAb (Abcam) and rabbit polyclonal MYC-tag antibody (Cat# 06-549, EMD Milipore). The immuno-reaction was detected by using anti-rabbit ReliaBLOT® HRP conjugate (Bethyl Laboratories) for 60 minutes prior to developing with ECL substrate solution (GE Healthcare) and exposure to film.
The views expressed in this manuscript are those of the authors and do not reflect the official policy of the Department of the Army, Department of Defense or the US Government.
Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J Clin 66, 7–30, doi:10.3322/caac.21332 (2016).
Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J Clin 65, 87–108, doi:10.3322/caac.21262 (2015).
Wilt, T. J. The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically localized prostate cancer. J Natl Cancer Inst Monogr 2012, 184–90, doi:10.1093/jncimonographs/lgs041 (2012).
Saylor, P. J. Prostate cancer: The androgen receptor remains front and centre. Nat Rev Clin Oncol 10, 126–8, doi:10.1038/nrclinonc.2013.14 (2013).
Hayward, S. W. et al. Epithelial development in the rat ventral prostate, anterior prostate and seminal vesicle. Acta Anat (Basel) 155, 81–93 (1996).
Ginsberg, J. P. et al. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing’s sarcoma. J Clin Oncol 17, 1809–14, doi:10.1200/JCO.19188.8.131.529 (1999).
Mitelman, F., Johansson, B. & Mertens, F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7, 233–45, doi:10.1038/nrc2091 (2007).
Sashida, G., Bazzoli, E., Menendez, S., Liu, Y. & Nimer, S. D. The oncogenic role of the ETS transcription factors MEF and ERG. Cell Cycle 9, 3457–9, doi:10.4161/cc.9.17.13000 (2010).
Tomlins, S. A. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644–8, doi:10.1126/science.1117679 (2005).
Sreenath, T. L., Dobi, A., Petrovics, G. & Srivastava, S. Oncogenic activation of ERG: A predominant mechanism in prostate cancer. J Carcinog 10, 37, doi:10.4103/1477-3163.91122 (2011).
Petrovics, G. et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene 24, 3847–52, doi:10.1038/sj.onc.1208518 (2005).
Carver, B. S. et al. ETS rearrangements and prostate cancer initiation. Nature 457, E1, discussion E2–3 (2009).
Rubin, M. A., Maher, C. A. & Chinnaiyan, A. M. Common gene rearrangements in prostate cancer. J Clin Oncol 29, 3659–68, doi:10.1200/JCO.2011.35.1916 (2011).
King, J. C. et al. Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis. Nat Genet 41, 524–6, doi:10.1038/ng.371 (2009).
Zong, Y. et al. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells. Proc Natl Acad Sci USA 106, 12465–70, doi:10.1073/pnas.0905931106 (2009).
Tomlins, S. A. et al. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 10, 177–88, doi:10.1593/neo.07822 (2008).
Klezovitch, O. et al. A causal role for ERG in neoplastic transformation of prostate epithelium. Proc Natl Acad Sci USA 105, 2105–10, doi:10.1073/pnas.0711711105 (2008).
Carver, B. S. et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet 41, 619–24, doi:10.1038/ng.370 (2009).
Chen, Y. et al. ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss. Nat Med 19, 1023–9, doi:10.1038/nm.3216 (2013).
Nguyen, L. T. et al. ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors. Cancer Cell 27, 797–808, doi:10.1016/j.ccell.2015.05.005 (2015).
Oakes, S. A. & Papa, F. R. The role of endoplasmic reticulum stress in human pathology. Annu Rev Pathol 10, 173–94, doi:10.1146/annurev-pathol-012513-104649 (2015).
Wu, X. et al. Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev 101, 61–9, doi:10.1016/S0925-4773(00)00551-7 (2001).
Halazonetis, T. D., Gorgoulis, V. G. & Bartek, J. An oncogene-induced DNA damage model for cancer development. Science 319, 1352–5, doi:10.1126/science.1140735 (2008).
Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–74, doi:10.1016/j.cell.2011.02.013 (2011).
Rouleau, M., Leger, J. & Tenniswood, M. Ductal heterogeneity of cytokeratins, gene expression, and cell death in the rat ventral prostate. Mol Endocrinol 4, 2003–13, doi:10.1210/mend-4-12-2003 (1990).
Mimnaugh, E. G., Xu, W., Vos, M., Yuan, X. & Neckers, L. Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade. Mol Cancer Res 4, 667–81, doi:10.1158/1541-7786.MCR-06-0019 (2006).
Sun, C. et al. TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation. Oncogene 27, 5348–5353, doi:10.1038/onc.2008.183 (2008).
Yu, J. et al. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 17, 443–54, doi:10.1016/j.ccr.2010.03.018 (2010).
Yang, Y. C. et al. Androgen receptor inclusions acquire GRP78/BiP to ameliorate androgen-induced protein misfolding stress in embryonic stem cells. Cell Death Dis 4, e607, doi:10.1038/cddis.2013.122 (2013).
Thomas, M. et al. The unfolded protein response modulates toxicity of the expanded glutamine androgen receptor. J Biol Chem 280, 21264–71, doi:10.1074/jbc.M500144200 (2005).
Nihei, Y. et al. Enhanced aggregation of androgen receptor in induced pluripotent stem cell-derived neurons from spinal and bulbar muscular atrophy. J Biol Chem 288, 8043–52, doi:10.1074/jbc.M112.408211 (2013).
Wanker, E. E. et al. Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. Methods Enzymol 309, 375–86, doi:10.1016/S0076-6879(99)09026-6 (1999).
Stenoien, D. L. et al. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet 8, 731–41, doi:10.1093/hmg/8.5.731 (1999).
Hoang, D. T. et al. Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer. Mol Cancer Ther 14, 713–26, doi:10.1158/1535-7163.MCT-14-0819 (2015).
Streicher, W. et al. Stilbene induced inhibition of androgen receptor dimerization: implications for AR and ARDeltaLBD-signalling in human prostate cancer cells. PLoS ONE 9, e98566, doi:10.1371/journal.pone.0098566 (2014).
Niu, Y. et al. Increased CK5/CK8-positive intermediate cells with stromal smooth muscle cell atrophy in the mice lacking prostate epithelial androgen receptor. PLoS ONE 6, e20202, doi:10.1371/journal.pone.0020202 (2011).
Abou-Kheir, W. G., Hynes, P. G., Martin, P. L., Pierce, R. & Kelly, K. Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten−/−TP53−/− prostate cancer model. Stem Cells 28, 2129–40, doi:10.1002/stem.538 (2010).
Lukacs, R. U., Goldstein, A. S., Lawson, D. A., Cheng, D. & Witte, O. N. Isolation, cultivation and characterization of adult murine prostate stem cells. Nat Protoc 5, 702–13, doi:10.1038/nprot.2010.11 (2010).
Wang, M. & Kaufman, R. J. The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat Rev Cancer 14, 581–97, doi:10.1038/nrc3800 (2014).
We are grateful to all members of the CPDR, USU for stimulating discussions; Ms. Elizabeth Umeda for mouse colony breeding, genotyping and maintenance; Dr. Dennis McDaniel and Ms. Kateryna Lund, USU Biomedical Instrumentation Center for TEM and FACS analysis and confocal microscopy ; Drs Rok Tkavc, Olga Grichenko, Ph.D. and Michael Daly, Department of Pathology for discussions and guidance in radiation experiments, Mr. Stephen Doyle, CPDR for the art work. This research was supported by the CPDR-USU program HU0001-10-2-0002, and the National Cancer Institute R01CA162383 grant to S.S.
The authors declare that they have no competing interests.
Change History: A correction to this article has been published and is linked from the HTML version of this paper. The error has not been fixed in the paper.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
An erratum to this article is available at https://doi.org/10.1038/s41598-017-09612-4.
Electronic supplementary material
About this article
Cite this article
Sreenath, T.L., Macalindong, S.S., Mikhalkevich, N. et al. ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development. Sci Rep 7, 1109 (2017). https://doi.org/10.1038/s41598-017-01187-4
Scientific Reports (2018)
Nature Reviews Urology (2018)